Standard Haematology Practice 2

Haematology in general practice.

Current problems in haematology. 2: Hereditary spherocytosis.

Hereditary spherocytosis is a relatively common haematological disorder and will be encountered by all haematologists. The abundance of new information, dealing principally with molecular and genetic aspects of pathophysiology, is beginning to have implications for its investigation and management. While these advances have not yet exerted a large influence at therapeutic level, the promise of ...

Biosimilar agents in oncology/haematology: from approval to practice

The regulation of biosimilars is a process that is still developing. In Europe, guidance regarding the approval and use of biosimilars has evolved with the products under consideration. It is now more than 3 years since the first biosimilar agents in oncology support, erythropoiesis-stimulating agents, were approved in the EU. More recently, biosimilar granulocyte colony-stimulating factors hav...

Angioplasty standard of practice.

PERCUTANEOUS transluminal angioplasty (PTA) and other methods of percutaneous revascularization have become established as effective therapy for selected patients with peripheral and renovascular occlusive diseases. Extensive literature now documents the safety and efficacy of PTA in the management of atherosclerotic and other vascular diseases (1–14). As with any invasive therapy, the potentia...

Haematology in Tropical Areas: Clinics in Haematology

CLINICS in Haematology were introduced some 10 years ago to provide in depth reviews of different aspects of the discipline and have become an accepted and highly respected part of haematology literature. To mark the 10th anniversary there has been a break from tradition and rather than dealing with a specialised topic, the present issue is devoted to Haematology in Tropical Areas. That the spe...